The FDA has approved Johnson & Johnson’s nipocalimab (Imaavy) for adults and paediatric patients 12 years of age and older with generalized myasthenia gravis (gMG) and anti-acetylcholine ...

A range of community projects have been supporting the challenge. Staff at the Mullard Space Science Laboratory in Dorking took part in a workshop, planting 20 fruit trees and three young oak ...

The FDA has approved Abeona Therapeutics’ prademagene zamikeracel (Zevaskyn) gene therapy for recessive dystrophic epidermolysis bullosa (DEB), a rare genetic skin disease. Prademagene ...

They have underpinned our discoveries and achievements, leading to better diagnosis and treatments. For example, a generous legacy gift from Mr Mullard enabled us to purchase a new flow cytometer ...